The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York GHK CU Apollo Peptide Sciences FDA Peptide Reclassification 2026: What It Means for Providers GLOW (BPC 157 GHK CU KPV TB500) Injections Team Wellcore GHK CU 107MG Thrive Peptides GHK Cu Hair & Scalp Serum 2400mg 4% Less Shedding Neurogan Neurogan Health